Showing 1 to 5 of 5 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers
MK-5909-005 (REJOICE-GI01) NCT06864169  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum Hepatic Ducts Oesophagus Pancreas Stomach |
Dr. Francine Aubin Adeline Hamon 514-890-8000 poste 30737 |
|
Lymph node oesophagus cancer
CT0075 n.d. Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Oesophagus |
Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
|
A Randomized Phase II Study of Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Positive Advanced Gastroesophageal Adenocarcinoma
CCTG GA4 NCT06043427 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Oesophagus Stomach |
Dr. Mustapha Tehfé Chantal Gosselin 514-890-8000 poste 24892 |
|
A Randomized Phase II Study of Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Positive Advanced Gastroesophageal Adenocarcinoma
CCTG GA4 NCT06043427 Recruiting
|
CIUSSS DU NORD-DE-L'ILE-DE-MONTREAL
HOPITAL DU SACRE-COEUR-DE-MONTREAL
|
Oesophagus Stomach |
Dr. Setareh Samimi Marie-Anne Capobianco 514-338-2222 poste 3493 |
|
A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician's Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma)
TroFuse-015 NCT06356311 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Oesophagus Stomach |
Dr. Sara Soldera |
Groupe d'étude en oncologie du Québec